- Investing Ideas
- /
- Australian Pharmaceuticals & Biotech Sustainable Track Record
Australian Pharmaceuticals & Biotech Sustainable Track Record
Results
2
0 new
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
2 companies
NeuroScientific Biopharmaceuticals
Market Cap: AU$5.1m
Engages in the research and development of novel peptide-based pharmaceutical products.
NSB
AU$0.035
7D
-2.8%
1Y
-41.7%
EZZ Life Science Holdings
Market Cap: AU$68.9m
Engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and internationally.
EZZ
AU$1.46
7D
0%
1Y
73.8%